Article Details

After a Scottish aye, NICE says no to Lynparza for prostate cancer - - Pharmaphorum

Retrieved on: 2022-01-05 16:10:24

Tags for this article:

Click the tags to see associated articles and topics

After a Scottish aye, NICE says no to Lynparza for prostate cancer - - Pharmaphorum. View article details on hiswai:

Excerpt

AstraZeneca's PARP inhibitor Lynparza should not be made available routinely on the NHS n England and Wales as a treatment for prostate cancer, ...

Article found on: pharmaphorum.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up